A plethora of studies has consistently emphasized the notable correlation between elevated TUBB3 expression and unfavorable prognoses across various malignancies, including lung, ovarian, and gastric cancers, establishing it as a prognostic indicator for cancer recurrence (72–74). This evidence concerns the gene TUBB3 and cancer.